文献速递肝胆胰外科

胰腺体部癌手术切除策略:多机构队列研究

Optimal strategies for surgical resection of pancreatic body cancer: A multi-institutional cohort study.
PubMed 文献 · Surgery · 2025-12-01

本研究回顾性比较了2013至2022年间16家机构中胰腺体部癌患者接受胰十二指肠切除术(PD)或远端胰腺切除术(DP)的结局。共纳入311例,其中PD组71例(23%),DP组240例(77%)。DP组术后胰瘘和Clavien-Dindo III级以上并发症发生率更高,R1切除率也显著更高,但两组无复发生存率和总生存率无显著差异;DP联合R1状态者生存更差。

要点

  • 胰腺体部癌行PD与DP的远期生存无显著差异。
  • DP术后胰瘘和严重并发症发生率高于PD。
  • DP的R1切除率显著高于PD,且R1状态者生存更差。

核心结论

  • 对于胰腺体部癌,胰十二指肠切除术可提供与远端胰腺切除术相当的结局。
  • 行远端胰腺切除术时需注意其并发症发生率高且R1切除风险更高。

研究设计与样本

  • 回顾性多机构队列研究,纳入2013至2022年间16家机构因胰腺体部癌行PD或DP的患者。
  • 共311例患者,其中71例(23%)行PD,240例(77%)行DP,并进行了倾向性评分匹配分析。

主要发现

  • PD与DP的无复发生存率和总生存率无显著差异。
  • DP联合R1状态者的生存差于PD或DP联合R0状态者。

临床怎么用

  • 胰腺体部癌选择术式时,PD可作为DP的替代方案,两者生存结局相当。
  • 行DP时应警惕更高的胰瘘、严重并发症及R1切除风险。

局限性

  • 本研究为回顾性研究,可能存在选择偏倚。
  • 样本量有限,PD组仅71例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pancreatic body cancer is usually considered alongside tail cancer, with distal pancreatectomy being the standard surgical approach. Nonetheless, the oncological effectiveness of distal pancreatectomy for pancreatic body cancer is uncertain, prompting consideration of pancreaticoduodenectomy as an alternative treatment. This study aimed to compare the outcomes of pancreaticoduodenectomy and distal pancreatectomy for pancreatic body cancer. METHODS: Clinicopathologic parameters, surgical outcomes, and survival of patients who underwent pancreaticoduodenectomy or distal pancreatectomy for pancreatic body cancer between 2013 and 2022 from 16 institutions were retrospectively compared. Propensity score-matched analysis adjusting patients' background characteristics was also performed. Risk factors for survival were identified by Cox proportional hazards model analysis. RESULTS: A total of 311 patients were enrolled; 71 (23%) underwent pancreaticoduodenectomy, and 240 (77%) underwent distal pancreatectomy. In the total cohort, the rates of postoperative pancreatic fistula (13% vs 25%, P = .024) and postoperative complications above Clavien-Dindo grade III (13% vs 28%, P = .005) were higher after distal pancreatectomy. The same tendency was observed in the propensity score-matched population. Notably, the R1 resection rate was significantly higher in distal pancreatectomy, in both total and propensity score-matched populations (1% vs 13%, P = .001 and 2% vs 17%, P = .001). Recurrence-free and overall survivals after pancreaticoduodenectomy and distal pancreatectomy were not significantly different. However, survival in distal pancreatectomy with R1 status was worse than in pancreaticoduodenectomy or distal pancreatectomy with R0 status. CONCLUSION: Pancreaticoduodenectomy for pancreatic body cancer can offer an equivalent outcome to distal pancreatectomy. Frequent complications and a higher risk of R1 resection should be noted when performing distal pancreatectomy.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Sato A, Anazawa T, Nagai K, et al. Optimal strategies for surgical resection of pancreatic body cancer: A multi-institutional cohort study. Surgery. 2025. PMID: 41330252. doi:10.1016/j.surg.2025.109930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。